ABCL three-lens brief
Evidence-based stock research on ABCL. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Price down 5.34% in the last session — a material single-day move. · Currently unprofitable on a trailing basis — no P/E multiple available.
- Price down 5.34% in the last session — a material single-day move.
- 50-day MA above 200-day MA (golden-cross regime); price above both.
- Outperforming SPY by 90.2pp over 30 days.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $17.13 — 64% above current (8 analysts).
ABCL closed at $10.46 (-5.34%) as of 2026-09-11. Market cap: $3.39B. Price is above the 50-day MA and above the 200-day MA. Positives: 50-day MA above 200-day MA (golden-cross regime); price above both.; outperforming SPY by 90.2pp over 30 days.. Concerns: price down 5.34% in the last session — a material single-day move.; currently unprofitable on a trailing basis — no P/E multiple available.. Last quarter: Revenue $4.05M, net income -$55.43M, free cash flow -$46.43M.
Why three lenses on ABCL, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ABCLacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ABCL" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ABCL brief"></iframe>